Showing results (51-60 of 239) with videos related to
Sort By:
Pageof 24
Treatments in Endocrinology|April 19, 2005
Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidismAlex J Brown, Daniel W CoyneCurrent Opinion in Nephrology and Hypertension|January 10, 2014
Update on intravenous iron choicesDerek S Larson, Daniel W CoyneKidney Research and Clinical Practice|February 20, 2016
Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney diseaseDerek S Larson, Daniel W CoyneKidney International|June 16, 2012
Bioavailable vitamin D in chronic kidney diseaseAlex J Brown, Daniel W CoyneMayo Clinic Proceedings|November 3, 2007
Use of erythropoiesis-stimulating agents in patients with anemia of chronic kidney disease: overcoming the pharmacological and pharmacoeconomic limitations of existing therapiesJay B Wish, Daniel W CoyneDrugs|April 20, 2016
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st CenturyGuy Rostoker, Nosratola D Vaziri, Steven FishbaneClinical Journal of the American Society of Nephrology : CJASN|January 11, 2014
Update on membranoproliferative GNNaveed Masani, Kenar D Jhaveri, Steven FishbaneJAMA Oncology|July 17, 2015
Nephrotoxicity of the BRAF Inhibitors Vemurafenib and DabrafenibKenar D Jhaveri, Vipulbhai Sakhiya, Steven FishbaneAdvances in Chronic Kidney Disease|September 4, 2019
Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney DiseasePablo E Pergola, Steven Fishbane, Tomas GanzKidney International|July 16, 2010
Hypothesis: an erythropoietin honeymoon phase existsSteven Fishbane, Nobuyuki Miyawaki, Lynda A SzczechPageof 24